Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

July 14, 2022

Primary Completion Date

April 4, 2023

Study Completion Date

April 4, 2023

Conditions
Antibody-mediated Rejection in Kidney Transplant
Interventions
OTHER

Chronic active AMR group

Past kidney transplant. This is a retrospective, non-interventional, observational study. No study treatment will be administered in this study.

OTHER

Non-Chronic active AMR group

Past kidney transplant. This is a retrospective, non-interventional, observational study. No study treatment will be administered in this study.

Trial Locations (3)

21201

University of Maryland School of Medicine, Div. of Nephrology, Baltimore

63130

The Washington University, St Louis

90033

Keck Medical Center of USC, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

UBC Late Stage (UK) Ltd.

UNKNOWN

lead

CSL Behring

INDUSTRY